Genetic background of systemic sclerosis: autoimmune genes take centre stage
- PMID: 19923204
- DOI: 10.1093/rheumatology/kep368
Genetic background of systemic sclerosis: autoimmune genes take centre stage
Abstract
SSc is a complex multiorgan disease. The key steps in its pathogenesis include early endothelial damage, dysregulation of the immune system with abnormal autoantibody production and fibroblast activation resulting in hyperproduction of extracellular matrix. The disease is caused by an interaction between susceptibility genes and environmental triggers since epidemiological data, including family and twin studies, reveal a genetic component in the pathogenesis of SSc. The candidate gene approach has mainly been employed to identify SSc susceptibility genes. We will focus on data obtained through large samples of well-phenotyped patients and replicated in independent cohorts. These case-control association studies have enabled the identification of several genes that are shared with other connective tissue disorders, and for some of these, putative autoimmune susceptibility genes have been identified. Indeed, we will mainly focus on IRF5 (rs2004640), STAT4 (rs7574865), PTPN22 (rs2476601) and BANK1 (rs3733197 and rs10516487) data. Some of these genes/loci are common to several autoimmune diseases, indicating a shared genetic background also contributing to SSc. Among connective tissue disorders, similarities for genetic markers with SLE are noteworthy. Most likely, these immune-modifying genes could interact and influence both disease phenotype and severity. Less evidence is available yet with regard to genetic markers relating to the vascular and fibrotic aspects of the disease.
Similar articles
-
The genetics of scleroderma (systemic sclerosis).Curr Opin Rheumatol. 2010 Mar;22(2):133-8. doi: 10.1097/BOR.0b013e3283367c17. Curr Opin Rheumatol. 2010. PMID: 20090527 Review.
-
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.Arthritis Rheum. 2009 Aug;60(8):2472-9. doi: 10.1002/art.24688. Arthritis Rheum. 2009. PMID: 19644887
-
Immunogenetics of systemic sclerosis.Autoimmun Rev. 2011 Mar;10(5):282-90. doi: 10.1016/j.autrev.2010.09.017. Epub 2010 Sep 21. Autoimmun Rev. 2011. PMID: 20863905 Review.
-
Updating the genetics of systemic sclerosis.Curr Opin Rheumatol. 2010 Nov;22(6):665-70. doi: 10.1097/BOR.0b013e32833d110a. Curr Opin Rheumatol. 2010. PMID: 20616736 Review.
-
Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.J Rheumatol. 2010 May;37(5):987-92. doi: 10.3899/jrheum.091163. Epub 2010 Mar 15. J Rheumatol. 2010. PMID: 20231204
Cited by
-
Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.Indian J Dermatol. 2013 Jul;58(4):255-68. doi: 10.4103/0019-5154.113930. Indian J Dermatol. 2013. PMID: 23918994 Free PMC article.
-
Genetics, Epigenetics, and Genomics of Systemic Sclerosis.Rheum Dis Clin North Am. 2015 Aug;41(3):345-66. doi: 10.1016/j.rdc.2015.04.001. Epub 2015 May 20. Rheum Dis Clin North Am. 2015. PMID: 26210123 Free PMC article. Review.
-
The vascular microenvironment and systemic sclerosis.Int J Rheumatol. 2010;2010:362868. doi: 10.1155/2010/362868. Epub 2010 Aug 10. Int J Rheumatol. 2010. PMID: 20814552 Free PMC article.
-
A preliminary study of possible fibrotic role of meprin metalloproteases in scleroderma patients.Arch Rheumatol. 2021 Jun 24;36(4):510-517. doi: 10.46497/ArchRheumatol.2021.8581. eCollection 2021 Dec. Arch Rheumatol. 2021. PMID: 35382369 Free PMC article.
-
Morphometric evaluation of nitric oxide synthase isoforms and their cytokine regulators predict pulmonary dysfunction and survival in systemic sclerosis.Braz J Med Biol Res. 2013 Oct;46(10):881-91. doi: 10.1590/1414-431X20133061. Epub 2013 Oct 12. Braz J Med Biol Res. 2013. PMID: 24141615 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous